The dramatic rise of oseltamivir resistance in the H1N1 serotype in the 2007/2008 season and the fixing of H274Y in the 2008/2009 season has raised concerns regarding individuals at risk for seasonal influenza, as well as development of similar resistance in the H5N1 serotype. Previously, oseltamivir resistance produced changes in H1N1 and H3N2 at multiple positions in treated patients. In contrast, the recently reported resistance involved patients who had not recently taken oseltamivir. Moreover, the resistance was limited to the H1N1 which had acquired H274Y. Using phylogenetic analysis I show that the fixing of H274Y was due to hitch hiking on a genetic background that acquired key changes from another circulating sub-clade. H274Y ...
The His274 → Tyr (H274Y) oseltamivir (Tamiflu) resistance mutation causes a substantial decrease in ...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
Background: In Spring 2009, a novel reassortant strain of H1N1 influenza A emerged as a lineage d...
The His^(274)→Tyr^(274) (H274Y) mutation confers oseltamivir resistance on N1 influenza neuraminidas...
Limited antiviral compounds are available for the control of influenza, and the emergence of resista...
Influenza A virus (IAV) is a major cause of morbidity and mortality throughout the world. Current an...
Neuraminidase (NA) inhibitors including oral oseltamivir and inhaled zanamivir are among the first l...
Neuraminidase (NA) inhibitors including oral oseltamivir and inhaled zanamivir are among the first l...
Conference Theme: Translating Health Research into Policy and Practice for Health of the PopulationP...
A naturally-occurring H275Y oseltamivir resistant variant of influenza A (H1N1) virus emerged in 200...
Neuraminidase (NA) inhibitors are one of two classes of antiviral compounds available for the contro...
Electronically published 4 May 2012.Background: Oseltamivir resistance in A(H1N1)pdm09 influenza is ...
A dramatic increase in the frequency of the H275Y mutation in the neuraminidase (NA), conferring res...
Influenza A virus (IAV) is a major cause of morbidity and mortality throughout the world. Current an...
The His274 → Tyr (H274Y) oseltamivir (Tamiflu) resistance mutation causes a substantial decrease in ...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
Background: In Spring 2009, a novel reassortant strain of H1N1 influenza A emerged as a lineage d...
The His^(274)→Tyr^(274) (H274Y) mutation confers oseltamivir resistance on N1 influenza neuraminidas...
Limited antiviral compounds are available for the control of influenza, and the emergence of resista...
Influenza A virus (IAV) is a major cause of morbidity and mortality throughout the world. Current an...
Neuraminidase (NA) inhibitors including oral oseltamivir and inhaled zanamivir are among the first l...
Neuraminidase (NA) inhibitors including oral oseltamivir and inhaled zanamivir are among the first l...
Conference Theme: Translating Health Research into Policy and Practice for Health of the PopulationP...
A naturally-occurring H275Y oseltamivir resistant variant of influenza A (H1N1) virus emerged in 200...
Neuraminidase (NA) inhibitors are one of two classes of antiviral compounds available for the contro...
Electronically published 4 May 2012.Background: Oseltamivir resistance in A(H1N1)pdm09 influenza is ...
A dramatic increase in the frequency of the H275Y mutation in the neuraminidase (NA), conferring res...
Influenza A virus (IAV) is a major cause of morbidity and mortality throughout the world. Current an...
The His274 → Tyr (H274Y) oseltamivir (Tamiflu) resistance mutation causes a substantial decrease in ...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infe...